Literature DB >> 22189518

For what reasons should metformin be used in the management of polycystic ovary syndrome?

P Moghetti1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22189518     DOI： 10.3275/8195

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  15 in total

1.  Ovulation induction in polycystic ovary syndrome.

Authors:  Tannys D R Vause; Anthony P Cheung
Journal:  J Obstet Gynaecol Can       Date:  2010-05

Review 2.  Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society.

Authors:  H F Escobar-Morreale; E Carmina; D Dewailly; A Gambineri; F Kelestimur; P Moghetti; M Pugeat; J Qiao; C N Wijeyaratne; S F Witchel; R J Norman
Journal:  Hum Reprod Update       Date:  2011-11-06       Impact factor: 15.610

3.  The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.

Authors:  Trevor J Orchard; Marinella Temprosa; Ronald Goldberg; Steven Haffner; Robert Ratner; Santica Marcovina; Sarah Fowler
Journal:  Ann Intern Med       Date:  2005-04-19       Impact factor: 25.391

Review 4.  Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.

Authors:  Robert A Wild; Enrico Carmina; Evanthia Diamanti-Kandarakis; Anuja Dokras; Hector F Escobar-Morreale; Walter Futterweit; Rogerio Lobo; Robert J Norman; Evelyn Talbott; Daniel A Dumesic
Journal:  J Clin Endocrinol Metab       Date:  2010-04-07       Impact factor: 5.958

Review 5.  Lifestyle changes in women with polycystic ovary syndrome.

Authors:  Lisa J Moran; Samantha K Hutchison; Robert J Norman; Helena J Teede
Journal:  Cochrane Database Syst Rev       Date:  2011-02-16

Review 6.  Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.

Authors:  J M Lord; I H K Flight; R J Norman
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 7.  Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

Authors:  Thomas Tang; Jonathan M Lord; Robert J Norman; Ephia Yasmin; Adam H Balen
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

8.  Consensus on infertility treatment related to polycystic ovary syndrome.

Authors: 
Journal:  Hum Reprod       Date:  2008-03       Impact factor: 6.918

Review 9.  The effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome.

Authors:  E Kassi; E Diamanti-Kandarakis
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256

10.  Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome?

Authors:  E Moll; J C Korevaar; P M M Bossuyt; F van der Veen
Journal:  Hum Reprod       Date:  2008-05-17       Impact factor: 6.918
View more
  1 in total

1.  How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology.

Authors:  P Moghetti; E Carmina; V De Leo; A Lanzone; F Orio; R Pasquali; V Toscano
Journal:  J Endocrinol Invest       Date:  2015-04-03       Impact factor: 4.256
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.